US$ 24.86
bpc-157 capsules third party tested Rapid bpc 157 capsules third party
Description
The primary measure of interest is the clinical outcome

Supports nerve health and reduces tingling, numbness, or weakness

Both compounds were presented once in 24 hours and examined on days 1, 2, 4, 7, and 14

The genetic test also evaluates FTO rs9939609 and MC4R rs17782313 variants, which relate to appetite regulation and metabolic response

BPC-157 restores equilibrium
The 40% contamination rate found in compounded semaglutide products applies broadly to the unregulated peptide market
